Your Daily Psychedelics & Therapy Briefing
Psilocybin, MDMA-assisted therapy, clinical trials, and the regulated psychedelic medicine movement. Get the latest psychedelics & therapy developments delivered to your inbox every morning. AI-powered, personalized, and grounded in real sources.
Eli Lilly's $3.8 Billion Psychedelic Bet Signals Market Validation Amidst Regulatory Clarity and State Research Push
North Carolina lawmakers are advancing "The HEAL Act," proposed legislation to establish a $5 million research grant for psychedelic-assisted therapy for trauma survivors. This initiative, focusing on therapy as a catalyst, aims to position the state in evidence-based research.
The Bottom Line
Substantial pharmaceutical investment, clearer federal regulatory pathways, and growing state-level research are rapidly maturing the psychedelic
Get Psychedelics & Therapy in your inbox every morning
Join readers who start their day with an AI-powered briefing on psychedelics & therapy and the topics they care about most — fully sourced and ready in 5 minutes.
Start your free trial7-day free trial · No credit card required
Related Briefings
Mental Health
Therapy research, workplace wellness, anxiety and depression treatments, and destigmatization efforts.
Pharmaceuticals
Drug approvals, clinical trials, pricing debates, and the pharmaceutical industry landscape.
Biotechnology
Gene editing, drug development, clinical trials, and the science of engineering biology.
Pick your topics
Psychedelics & Therapy, plus anything else you follow
We research overnight
AI synthesizes real-time sources while you sleep
Read in 5 minutes
Cited, structured, no fluff — in your inbox every morning